Full Press Release Details
NATICK, Mass. , Sept. 28, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Court of Appeals for the Federal Circuit found in favor of the Company in a 1998 patent infringement suit involving Johnson & Johnson.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding litigation outcome, our product and litigation strategy, product design and performance and competitive offerings. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.
| CONTACT: | Denise Kaigler | |
| 508-650-8330 (office) | ||
| Media Relations | ||
| Boston Scientific Corporation | ||
| [email protected] | ||
| Erik Kopp | ||
| 508-650-8660 (office) | ||
| Media Relations | ||
| Boston Scientific Corporation | ||
| [email protected] | ||
| Sean Wirtjes | ||
| 508-652-5305 (office) | ||
| Investor Relations | ||
| Boston Scientific Corporation | ||
| [email protected] |
SOURCE Boston Scientific Corporation